Investigating the impact of treatment on new HIV infections: New PLoS collection

July 10, 2012

Is it possible to cut HIV transmission by using antiretroviral treatment? A collection of new articles published in the open-access journal PLoS Medicine, in conjunction with the HIV Modelling Consortium, addresses this pressing question.

The PLoS Medicine articles provide insights into the feasibility of interventions, their potential epidemiological impact and affordability, and recent scientific and community trials, which will support evidence-based decision-making on the use of antiretroviral treatment to prevent .

The background to this collection comes from a November 2011 meeting in Stellenbosch, South Africa, which focused on the cross-cutting issues that will affect the impact of new scientific findings about HIV treatment preventing new infections. As the introductory article "HIV Treatment as Prevention: Models, Data and Questions Towards Evidence-based Decision-Making" explains, over the past two years there have been several positive advances in HIV prevention research.

In particular, the authors say: "The finding that has created the greatest excitement has been that HIV-infected individuals who are given antiretroviral treatment (ART) are much less likely to transmit the infection to their heterosexual partners than those who are not." Currently ART is directed at those in greatest clinical need, and expanding the group of people treated would be a substantial change in health policy. It would also have a huge associated cost.

The volume of information needed to make efficient and ethical regarding HIV treatment as prevention is vast, and mathematical models can help pull the information together and structure it in a useful way. One focus of the collection is to evaluate the utility of these models by assessing the level of consistency between them—and between the models and data collected from the real world.

The choice of which particular groups to expand access to ART to depends on a wide range of considerations including, for example, which groups are easiest to access and which groups are most likely to reduce onward transmission. Decisions regarding as prevention are not only practical but ethical, argue leading authors in the series; as on HIV prevention is limited by resource constraints, the authors review how to expand the provision of ART and who to expand it to.

This collection, "Investigating the Impact of Treatment on New HIV Infections", publishes two weeks prior to the AIDS 2012 conference in Washington D.C., which editors and collection authors will be attending.

Explore further: Hope for more options in couples where one partner is HIV positive

More information: www.ploscollections.org/TasP2012

Related Stories

Hope for more options in couples where one partner is HIV positive

November 15, 2011
In sub-Saharan Africa, couples in long-term relationships where one partner is HIV-positive and the other is HIV-negative (HIV serodiscordant couples) could benefit from anti-AIDS drugs (antiretroviral therapy) given either ...

New book on HIV from Cold Spring Harbor Laboratory Press

December 15, 2011
The worldwide AIDS epidemic makes research on HIV, the disease processes it induces, and potential HIV therapies among the most critical in biomedical science. Furthermore, the basic biology of HIV infections provides a model ...

Roll out treatment as prevention now to stop HIV and AIDS

July 14, 2011
The Lancet, a leading global medical journal, published an editorial comment today that emphasizes the critical role of expanding access to HIV treatment under a "Treatment as Prevention" strategy to stop the HIV pandemic.

Recommended for you

Study suggests a way to stop HIV in its tracks

December 1, 2017
When HIV-1 infects an immune cell, the virus travels to the nucleus so quickly there's not enough time to set off the cell's alarm system.

Discovery puts the brakes on HIV's ability to infect

November 30, 2017
Viewed with a microscope, the virus faintly resembles a pineapple—the universal symbol of welcome. But HIV, the virus that causes AIDS, is anything but that. It has claimed the lives of more than 35 million people so far.

Rising levels of HIV drug resistance

November 30, 2017
HIV drug resistance is approaching and exceeding 10% in people living with HIV who are about to initiate or reinitiate first-line antiretroviral therapy, according to the largest meta-analysis to date on HIV drug resistance, ...

Male circumcision and antiviral drugs appear to sharply reduce HIV infection rate

November 29, 2017
A steep drop in the local incidence of new HIV infections accompanied the rollout of a U.S.-funded anti-HIV program in a large East-African population, according to a study led by researchers at Johns Hopkins Bloomberg School ...

Combination HIV prevention reduces new infections by 42 percent in Ugandan district

November 29, 2017
A study published today in the New England Journal of Medicine provides real-world evidence that implementing a combination of proven HIV prevention measures across communities can substantially reduce new HIV infections ...

Research on HIV viral load urges updates to WHO therapy guidelines

November 24, 2017
A large cohort study in South Africa has revealed that that low-level viraemia (LLV) in HIV-positive patients who are receiving antiretroviral treatment (ART) is an important risk factor for treatment failure.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.